Clinical Trials Sponsored by Aposense Ltd.

Total 17041 results

University Hospital Southampton NHS Foundation...
Biosense Webster, Inc.

Not yet recruiting

Randomised Comparison of the Octaray and Pentaray Catheters (COPEC)

Atrial Fibrillation
University of Sao Paulo General Hospital
Biosense Webster, Inc.

Recruiting

Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas Disease

Chagas Cardiomyopathy | Ventricular Arrythmia

Brazil
University of Sao Paulo General Hospital
Biosense Webster, Inc.

Completed

Efficacy and Safety of Epicardial VT Ablation Using Contact Force Irrigated Tip Catheter - Pilot Study

Tachycardia, Ventricular

Brazil
Maastricht University Medical Center
Boston Scientific Corporation; BaroSense Inc.

Completed

ACE Stapler Sub Study

Obesity

Netherlands
Mirka Ltd
Clinius Ltd

Completed

A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty Skin

Keratosis, Actinic | Hyperkeratotic Callus | Actinic Lesion | Solar Keratosis/Sunburn | Hyperkeratosis | Hyperkeratotic; Lesion | Hyperkeratotic Actinic Keratosis

Finland
The Leeds Teaching Hospitals NHS Trust
Biosense Webster, Inc.

Completed

The VERISMART Trial (VERISMART)

Atrial Flutter

United Kingdom
Weill Medical College of Cornell University
Biosense Webster, Inc.

Completed

Contrast ICE for Myocardial Scar in VT Ablations

Ventricular Tachycardia | Ischemic Cardiomyopathy
Gregory Jones
Biosense Webster, Inc.

Completed

ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation (ICE)

Atrial Fibrillation

United States
David B. De Lurgio
Biosense Webster, Inc.

Completed

Cardioneuroablation for Neurocardiogenic Syncope (Ablate-NCS)

Neurocardiogenic Syncope | Vasovagal Syncope

United States
Hospital Universitario Virgen de la Arrixaca
Biosense Webster, Inc.

Unknown

SmartTouch Catheter in Ablation of Ventricular Tachycardia

Myocardial Infarction | Arrhythmias, Cardiac | Cardiomyopathies | Tachycardia, Ventricular

Spain
Salus Ltd.
TheraVitae Ltd.

Completed

Autologous Angiogenic Cell Precursors (ACPs) for the Treatment of Peripheral Artery Disease

Critical Limb Ischemia

Hungary
Janssen-Cilag Farmaceutica Ltda.
Janssen Korea, Ltd., Korea

No longer available

An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes

Hong Kong, Brazil, Thailand
Scott Martin Miller, MD
Biosense Webster, Inc.

Terminated

Atrial Pressure Electrophysiology Pilot Study (APES)

Atrial Fibrillation

United States
Heart Rhythm Clinical and Research Solutions, LLC
Biosense Webster, Inc.

Recruiting

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation. (QDOT PAS)

Paroxysmal Atrial Fibrillation

United States
Heart and Diabetes Center North-Rhine Westfalia
Biosense Webster, Inc.

Completed

Catch me if You Can - the Individual Relationship Between Potential Ablation Targets From CARTOFINDER and Myocardial Fibrosis

Atrial Fibrillation

Germany
Icahn School of Medicine at Mount Sinai
Biosense Webster, Inc.

Terminated

INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events (INTERVENE)

Ventricular Tachycardia

India
Elad Anter
Biosense Webster, Inc.

Completed

Comparison of Intracardiac Echocardiography and Transesophageal Echocardiography (ICE-TEE)

Atrial Fibrillation | Atrial Flutter

United States
Paion UK Ltd.
Chiltern International Ltd.; HFL Ltd.

Completed

An Efficacy and Safety Study to Compare Morphine 6-glucuronide (M6G) and Morphine in Patients Suffering With Post-Operative Pain for at Least 24 Hours

Postoperative Pain

France, Germany, Netherlands, Poland, United Kingdom, Czechia
Cardiovalve Ltd.
Meditrial Europe Ltd.

Recruiting

Cardiovalve Transfemoral System - FIM Study

Mitral Regurgitation

Lithuania
Vensica Therapeutics Ltd.
Blueclinical, Ltd.

Completed

Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female Subjects (XAVIER)

Overactive Bladder

Portugal
Nanomedic Technologies Ltd.

Completed

Evaluation of the SpinCare™ System in the Treatment of Partial Thickness Burns (SPINCARE2)

Partial Thickness Burn

Israel
Nanomedic Technologies Ltd.

Completed

Evaluation of the SPINNER Device for the Application of Wound Dressing: Treatment of Split Skin Graft Donor Sites (SPINNER01)

Wound of Skin

Israel
Danisco
4Pharma Ltd.; Medfiles Ltd.

Completed

Next Generation Probiotics (NGPs) for Metabolic Health

Microbial Colonization
Calcivis Ltd
Medsource UK Ltd.

Completed

Safety and Performance Evaluation of the Calcivis System

Dental Caries

United Kingdom
Targia Pharmaceuticals Ltd.
SoluBest Ltd.

Unknown

Comparative Bioavailability Study of Omexa Sumatriptan vs. Imitrex® in Healthy Volunteers

Migraine
Xention Ltd
Ario Pharma Ltd

Completed

A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
TyrNovo Ltd.

Active, not recruiting

A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer

Head and Neck Cancer | Squamous Cell Carcinoma of Head and Neck | Metastatic Solid Tumor | Colorectal Adenocarcinoma | Solid Tumor, Adult | Recurrent Solid Tumor

United States, Israel
Xention Ltd
Ario Pharma Ltd

Completed

A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With Chronic Idiopathic Cough

Chronic Idiopathic Cough

United Kingdom, Ireland
Calcivis Ltd
Medsource UK Ltd.

Completed

Caries Lesion Activity in Orthodontic Patients - Calcivis System

Dental Caries

United Kingdom
Heart Rhythm Clinical and Research Solutions, LLC
Biosense Webster, Inc.

Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation (REAL-AF)

Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation

United States
Mercy Research
Washington University School of Medicine; Biosense Webster, Inc.

Enrolling by invitation

Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia

Ventricular Tachycardia

United States
Fundacion para la Innovacion en Biomedicina (FIBMED)
Biosense Webster, Inc.

Active, not recruiting

Hybrid Characterization of Driver Sites During Atrial Fibrillation and Sinus Rhythm (Hybrid-AFMAP)

Persistent Atrial Fibrillation

Spain
René Husted Worck
Biosense Webster, Inc.

Completed

PeAF-BOX: Feasibility, Safety and Efficacy of PVI + Box Ablation in Persistent Atrial Fibrillation (PeAF-BOX)

Atrial Fibrillation
University of Pennsylvania
Biosense Webster, Inc.; Texas Cardiac Arrhythmia Research Foundation

Active, not recruiting

First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3) (RAAFT-3)

Atrial Fibrillation

United States
Rigshospitalet, Denmark
Medtronic; Abbott Medical Devices; Biosense Webster, Inc.; Guidant Corporation

Completed

A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial Fibrillation

Atrial Fibrillation | Arrhythmia

Denmark
Liverpool Heart and Chest Hospital NHS Foundation...
Biosense Webster, Inc.

Unknown

Pulmonary Vein Reconnection Following Ablation Index-guided Ablation: a Success Evaluation (PRAISE)

Atrial Fibrillation

United Kingdom, Italy
Spyridon Deftereos
Biosense Webster, Inc.

Unknown

Prophylactic Substrate Ablation in Post-myocardial Patients Undergoing Defibrillator Implantation.

Myocardial Infarction | Heart Failure | Ventricular Tachycardia
Liverpool Heart and Chest Hospital NHS Foundation...
Biosense Webster, Inc.

Completed

The Effect of Early Repeat Atrial Fibrillation (AF) Ablation on AF Recurrence (PRESSURE)

Atrial Fibrillation

United Kingdom
Neurovalens Ltd.
University College Dublin; Exploristics Ltd; Compliance Solutions Ltd.

Completed

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Reducing Excess Body Weight

Obesity | Overweight | Metabolic Syndrome | Overweight and Obesity | Overweight or Obesity

Ireland
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Recruiting

Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers

Bioequivalence

Greece
Impact Biotech Ltd
Impact biotech Ltd.

Not yet recruiting

Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma

Locally Advanced Unresectable Pancreatic Adenocarcinoma
Enzene Biosciences Ltd.
Alkem Laboratories Ltd

Recruiting

Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers

Healthy Male Subjects

Bulgaria, Poland
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Recruiting

A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions

Asthma | Bioequivalence

Greece
Acacia Pharma Ltd
Paion UK Ltd.

Active, not recruiting

Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures

Pediatric ALL

United States, Denmark
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Active, not recruiting

A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 250 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions

Asthma | Bioequivalence

Greece
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Completed

A Pivotal Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 500/50 Inhalation Powder/GSK in Healthy Volunteers

Bioequivalence

Greece
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Completed

A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade (BREATH-PK250-CC)

Bioequivalence

Greece
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Completed

A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Bioequivalence

Greece
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Completed

A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy Volunteers (BREATH-PK500)

Bioequivalence

Greece
Beta-Stim Ltd.
Meditrial Europe Ltd.

Completed

Balance System Study in Type 2 Diabetic Patients

Obesity | Type 2 Diabetes

Germany

Clinical Trials Sponsored by Aposense Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations